Recombinant tPA administered within 4.5 hours of onset combined with mechanical thrombectomy within 6 hours is argued to be the preferred treatment of proximal cerebral artery occlusion.16 The American Heart Association has similar guidelines regarding stroke occlusion of the proximal middle cerebral or internal carotid artery. This evidence concerns the gene PLAT and stroke disorder.